[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550888":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":20,"responsibleParty":30,"collaborators":20,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":20,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":20,"enrollmentInfo":43,"targetDuration":20,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":56,"overallStatus":63,"whyStopped":20,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":20},{"fullName":5,"class":6},"EEPiDuDa Study Group","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Endoscopic Enucleation of the Prostate","OTHER","Patients with urodynamically proven Detrusor Underactivity\u002FAcontractility, who undergo endoscopic enucleation of the prostate (EEP).",[13],"Procedure: Endoscopic enucleation of the prostate",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Endoscopic enucleation of the prostate","Endoscopic enucleation of the prostate, regardless of energy source.\n\nAlso see:\n\n* Enucleation is enucleation is enucleation is enucleation\n* PMID: 27585786 DOI: 10.1007\u002Fs00345-016-1922-3",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Pawel Trotsenko, Dr. med. Dr. med. univ.","CONTACT","004369919479989","pawel.trotsenko@gmx.at",{"name":28,"role":24,"phone":20,"phoneExt":20,"email":29},"Thomas RW Herrmann, Prof.","thomas.herrmann@stgag.ch",{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Pawel Trotsenko","Dr. med. Dr. med. univ.","100550888","eep-in-patients-with-urodynamically-proven-duda-100550888",false,"NCT06452927","EEP in Patients With Urodynamically Proven DU\u002FDA","Endoscopic Enucleation of the Prostate in Patients With Urodynamically Proven Detrusor Underactivity\u002FAcontractility","Inclusion Criteria:\n\n* Endoscopic enucleation of the prostate in patients with DU\u002FDA secondary to a non-neurogenic aetiology:\n\n  * Detrusor underactivity (DU) defined urodynamically as a bladder contractility index (BCI) of \\\u003C100.\n  * Detrusor acontractility (DA) defined urodynamically as the absence of a detrusor contraction despite filling to bladder capacity.\n\nExclusion Criteria:\n\n* Neurogenic aetiology for DU\u002FDA (Parkinson, stroke…)\n* Other surgical approaches for the treatment of benign prostate hyperplasia (Aquaablation, open enucleation of the prostate, open prostatectomy, transurethral resection of the prostate...)","MALE","40 Years",{"count":44,"type":45},300,"ESTIMATED","INTERVENTIONAL",[48],"NA","The aim of this project is to create und evaluate a multicentral, retro-\u002Fprospective database for patients with urodynamically proven detrusor underactivity (DU) or acontractility (DA) secondary to a non-neurogenic aetiology, who undergo endoscopic, anatomic enucleation of the prostate (EEP).",[51,52,53,54,55],"Lower Urinary Tract Symptoms","Lower Urinary Tract Obstructive Syndrome","Detrusor Underactivity","Detrusor Areflexia","Prostatic Hyperplasia",[9,57,58,53,59,60,61,62],"BipoEP","ThuLEP","Detrusor Acontractility","HoLEP","Urodynamics","Pressure Flow Study","NOT_YET_RECRUITING","2024-06-06",{"date":66,"type":67},"2024-06-11","ACTUAL",{"date":69,"type":45},"2024-09",{"date":71,"type":45},"2028-09",{"name":5,"class":6}]